Table II.
IC50 of Different Lung Cancer Cells for Docetaxel Solution and Docetaxel Liposome over a Period of 24 and 48 h
| Treatment | Cell line | 24 H | 48 H |
|---|---|---|---|
| DTX Solution (μM) | A549 | 0.95 | 0.43 |
| H460 | ˃2 | 0.37 | |
| DTX Liposome (μM) | A549 | 0.23 | 0.32 |
| H460 | ˃2 | 0.20 |
IC50 of Different Lung Cancer Cells for Docetaxel Solution and Docetaxel Liposome over a Period of 24 and 48 h
| Treatment | Cell line | 24 H | 48 H |
|---|---|---|---|
| DTX Solution (μM) | A549 | 0.95 | 0.43 |
| H460 | ˃2 | 0.37 | |
| DTX Liposome (μM) | A549 | 0.23 | 0.32 |
| H460 | ˃2 | 0.20 |